Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial
- Author
- MASSIE, Barry M1 ; ARMSTRONG, Paul W2 ; CLELAND, John G. F3 ; HOROWITZ, John D4 ; PACKER, Milton5 ; POOLE-WILSON, Philip A6 ; RYDEN, Lars7
[1] Departments of Medicine, University of California-San Francisco and the Department of Veterans Affairs Medical Center, San Francisco, United States
[2] University of Alberta, Edmonton, Canada
[3] University of Hull, Kingston upon Hull, United Kingdom
[4] Cardiac Unit, University of Adelaide, Adelaide, South Australia, Australia
[5] Department of Circulatory Physiology, College of Physicians and Surgeons, Columbia University, New York, NY, United States
[6] Department of Cardiology, Imperial College School of Medicine, University of London, London, United Kingdom
[7] Department of Medicine, the Karolinska Institutet, Stockholm, Sweden - Source
Archives of internal medicine (1960). 2001, Vol 161, Num 2, pp 165-171 ; ref : 22 ref
- CODEN
- AIMDAP
- ISSN
- 0003-9926
- Scientific domain
- General medicine general surgery
- Publisher
- American Medical Association, Chicago, IL
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Chronique Dose faible Dose forte Effet secondaire Efficacité traitement Etude comparative Homme Insuffisance cardiaque Lisinopril Pharmacocinétique Sécurité Voie orale Antihypertenseur Appareil circulatoire pathologie Cardiopathie Inhibiteur angiotensin converting enzyme Pharmacologie
- Keyword (en)
- Chronic Low dose High dose Secondary effect Treatment efficiency Comparative study Human Heart failure Lisinopril Pharmacokinetics Safety Oral administration Antihypertensive agent Cardiovascular disease Heart disease ACE inhibitor Pharmacology
- Keyword (es)
- Crónico Dosis débil Dosis fuerte Efecto secundario Eficacia tratamiento Estudio comparativo Hombre Insuficiencia cardíaca Lisinopril Farmacocinética Seguridad Vía oral Antihipertensivo Aparato circulatorio patología Cardiopatía Inhibidor angiotensin converting enzyme Farmacología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F09 Miscellaneous
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 858772
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1001/archinte.161.2.165 
https://dx.doi.org/10.1001/archinte.161.2.165
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archinte.161.2.165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MASSIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Barry M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"ARMSTRONG, Paul W\";i:1;s:18:\"CLELAND, John G. F\";i:2;s:16:\"HOROWITZ, John D\";i:3;s:14:\"PACKER, Milton\";i:4;s:22:\"POOLE-WILSON, Philip A\";i:5;s:11:\"RYDEN, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archinte.161.2.165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MASSIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Barry M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"ARMSTRONG, Paul W\";i:1;s:18:\"CLELAND, John G. F\";i:2;s:16:\"HOROWITZ, John D\";i:3;s:14:\"PACKER, Milton\";i:4;s:22:\"POOLE-WILSON, Philip A\";i:5;s:11:\"RYDEN, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archinte.161.2.165\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archinte.161.2.165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MASSIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Barry M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"ARMSTRONG, Paul W\";i:1;s:18:\"CLELAND, John G. F\";i:2;s:16:\"HOROWITZ, John D\";i:3;s:14:\"PACKER, Milton\";i:4;s:22:\"POOLE-WILSON, Philip A\";i:5;s:11:\"RYDEN, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archinte.161.2.165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MASSIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Barry M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"ARMSTRONG, Paul W\";i:1;s:18:\"CLELAND, John G. F\";i:2;s:16:\"HOROWITZ, John D\";i:3;s:14:\"PACKER, Milton\";i:4;s:22:\"POOLE-WILSON, Philip A\";i:5;s:11:\"RYDEN, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archinte.161.2.165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Archives of internal medicine (1960)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Arch. intern. med. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"161\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"165\";s:8:\"\u0000*\u0000epage\";s:3:\"171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-9926\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"MASSIE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Barry M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"ARMSTRONG, Paul W\";i:1;s:18:\"CLELAND, John G. F\";i:2;s:16:\"HOROWITZ, John D\";i:3;s:14:\"PACKER, Milton\";i:4;s:22:\"POOLE-WILSON, Philip A\";i:5;s:11:\"RYDEN, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMDAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:138:\"Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic Heart failure : Results from the ATLAS trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
